Form 10-Q · Quarterly report
Chevron Corporation 10-Q, filed Aug 6, 2026
- Filed
- CIK
- 0000093410
- Accession no.
- 0000093410-26-000167
Summary
Chevron reported second-quarter 2026 net income attributable to the company of $12.1 billion, or $6.11 per diluted share, up from $2.5 billion, or $1.45 per diluted share, a year earlier, driven by higher upstream realizations and sales volumes and higher downstream refined-product margins.
Key points
- Second-quarter 2026 Upstream earnings were $8.2 billion, compared with $2.7 billion in second-quarter 2025.
- Second-quarter 2026 Downstream earnings were $4.9 billion, compared with $737 million a year earlier.
- First-half 2026 net income attributable to Chevron was $14.3 billion, or $7.21 per diluted share, compared with $6.0 billion, or $3.45 per diluted share, in first-half 2025.
- Total segment earnings were $13.05 billion in second-quarter 2026, compared with $3.46 billion in the corresponding 2025 period.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations Second Quarter 2026 Compared with Second Quarter 2025 Key Financial Results Earnings by Business Segment Three Months Ended June 30 Six Months Ended June 30 2026 2025 2026 2025 (Millions of dollars) (Millions of dollars) Upstream United States $ 3,541 $ 1,418 $ 5,653 $ 3,276 International 4,641 1,309 6,438 3,209 Total Upstream 8,182 2,727 12,091 6,485 Downstream United States 2,411 404 2,607 507 International 2,457 333 1,444 555 Total Downstream 4,868 737 4,051 1,062 Total Segment Earnings 13,050 3,464 16,142 7,547 All Other (978) (974) (1,860) (1,557) Net Income (Loss) Attributable to Chevron…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.